Delivering timely service and evidence-informed resources to people in BC and the Yukon facing cancer and those involved in oncology care or research.
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency KEL Library | Available |
Contents:; Sec 1. Practice standards and competencies -- Sec 2. Infection prevention and control -- Sec 3. Management of Perioperative Care -- Sec 4. Safety Considerations and Responsibilities -- Sec 5. Response Management in the Perioperative Setting -- Sec 6. Glossary.
c.1 BC Cancer Agency VAN Library | Available | ||
c.2 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available |
Contents:; Sec 1. Practice standards and competencies -- Sec 2. Infection prevention and control -- Sec 3. Perioperative phases / Anesthesia / Surgical energy / Specific care management -- Sec 4. Risk managment and occupation health and safety -- Sec 5. Exceptional clinical events -- Sec 6. Glossar…
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
Contents:; Sec 1. Practice standards and competencies -- Sec 2. Infection prevention and control -- Sec 3. Management of perioperative care -- Sec 4. Risk management and occupation health and safety -- Sec 5. Exceptional clinical events -- Sec 6. Glossary.
c.1 BC Cancer Agency VIC Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency KEL Library | Available |
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency ARHCC Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
The series is primarily intended to document the disease classifications used in the Population Health Impact of Disease in Canada (PHI) research program and help researchers to understand how the PHI estimates were calculated. It is also of interest to health professionals, advocacy groups, and in…
c.1 BC Cancer Agency VAN Library | Available |
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VIC Library | Available |
c.1 BC Cancer Agency VAN Library | Available |
v.1: Patient safety and quality; Evidence-based practice; Patient-centered care; v.2: Working conditions : work environment; Critical opportunities for patient safety and quality; v.3: Tools for improvement
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available | ||
c.1 BC Cancer Agency VAN Library | Available |
This publication represents the views and expert opinions of an IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, which met in Lyon, 2-9 February 2016
PART I: INTRODUCTION AND BACKGROUND; 1 INTRODUCTION; 2 CANNABIS; 3 CANNABIS: PREVALENCE OF USE, REGULATION, AND CURRENT POLICY LANDSCAPE; PART II: THERAPEUTIC EFFECTS; 4 THERAPEUTIC EFFECTS OF CANNABIS AND CANNABINOIDS; PART III: OTHER HEALTH EFFECTS; 5 CANCER; 7 RESPIRATORY DISEASE; 8 IMMUNITY; 9…